Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.14 | 0.14 | 0.00 |
Stocks | 99.86 | 99.86 | 0.00 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 14.56 | 19.60 |
Price to Book | 3.10 | 3.69 |
Price to Sales | 1.05 | 2.35 |
Price to Cash Flow | 6.48 | 13.52 |
Dividend Yield | 1.14 | 1.62 |
5 Years Earnings Growth | 12.41 | 11.60 |
Name | Net % | Category Average |
---|---|---|
Technology | 28.07 | 26.45 |
Consumer Cyclical | 16.36 | 10.24 |
Financial Services | 14.10 | 14.22 |
Healthcare | 12.62 | 13.69 |
Industrials | 10.40 | 10.17 |
Energy | 6.34 | 4.48 |
Communication Services | 5.61 | 8.20 |
Basic Materials | 5.41 | 2.75 |
Utilities | 1.08 | 2.49 |
Number of long holdings: 85
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft | US5949181045 | 3.86 | 423.85 | -0.16% | |
Amazon.com | US0231351067 | 3.26 | 184.30 | -0.38% | |
Apple | US0378331005 | 3.16 | 196.89 | +1.24% | |
NVIDIA | US67066G1040 | 3.09 | 1,208.61 | -0.11% | |
Molina Healthcare | US60855R1005 | 2.39 | 309.56 | -1.23% | |
Cencora Inc | US03073E1055 | 2.03 | 235.47 | -0.51% | |
Amgen | US0311621009 | 1.94 | 305.01 | -0.22% | |
Builders FirstSource | US12008R1077 | 1.89 | 146.28 | +0.44% | |
JPMorgan | US46625H1005 | 1.80 | 199.95 | +1.54% | |
Alphabet A | US02079K3059 | 1.80 | 174.45 | -1.29% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Bridgeway Omni Small-Cap Value N | 1.2B | -0.47 | 5.88 | 7.91 | ||
Bridgeway Ultra-Small Company Marke | 172.67M | -2.03 | -4.01 | 4.97 | ||
Bridgeway Ultra-Small Company | 79.54M | -1.33 | 1.83 | 5.20 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review